Edward C.C. Wong: Navigating the Implications of the 2026 ASH Guidelines for Blood Donation
Edward C.C. Wong, Medical Director of Coagulation at Quest Diagnostics, shared a post on LinkedIn:
“Honored to be able to moderate an educational session on ‘The Potential Impact of the 2026 American Society of Hematology Guidelines on Blood Donation’ at AABB National Meeting in Atlanta, GA.
Is it an existential threat to blood donation or could it be an improvement to blood donation and the nation’s blood supply?
Should blood centers be more actively involved in the health and well being of its blood donors like other countries such as Canada, the Netherlands and Australia?
Should we monitor ferritin in our donors?
This session had two outstanding speakers Alan Mast from Versiti and Ralph Vassallo from Vitalant who shed light on these questions.
Session: AM26-SU-07-L – Potential Impact of the 2026 ASH Guidelines for Iron Deficiency on Blood Donation: The Good, the Bad, and the Ugly (October 18, 2026).”
Stay updated with Hemostasis Today.
-
Oct 30, 2026, 15:40Isabella Presch: The Practicalities of Gene Therapy Adoption in Hemophilia
-
Oct 30, 2026, 14:53Pall T. Onundarson: Anticoagulation Guidelines Under the Influence of Pharmaceuticalisation
-
Oct 30, 2026, 14:27Isabella Presch: From Innovation to Accessibility in Cell and Gene Therapy
-
Oct 30, 2026, 14:00Abdul Mannan: A Negative PCR Does Not Exclude β-Thalassaemia
-
Oct 30, 2026, 13:53Matteo Foschi: Can Thrombolysis Safely Treat Stroke After Cardiac Procedures?
-
Oct 30, 2026, 13:42Wolfgang Miesbach: Gene Therapy-Associated Leukaemia With Clonal Persistence Over 16 Years
-
Oct 30, 2026, 12:47Louise St. Germain Bannon: Turning Thrombosis Awareness into Stroke Prevention
-
Oct 30, 2026, 12:36Aryabhatta Sadhu: Sickle Cell Crisis Recognising When Treatment Must Change
-
Oct 30, 2026, 12:22Fabrice Cognasse: The Future of Blood Banks From Transfusion Support to Precision Medicine